Skip to main content

Table 2 Antimicrobial susceptibility profiles for invasive and noninvasive S agalactiae isolates

From: Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiaein a Latin American hospital: a 17-year study

Antibiotic 1994-2001S. agalactiaesusceptibility (%) 2004-2012S. agalactiaesusceptibility (%)
  Invasive Noninvasive Invasive Noninvasive
Ampicillin 100 98.3 95.4 99.1
Penicillin 100 97.5 96.3* 99
Clindamycin 93 94.5 90.7 91.4
Erythromycin 97.5 97 85.3 88.2
Levofloxacin - - 96.9 97.6
Tetracycline 21.4 8.1 9.4 11.9
Vancomycin 100 100 100 99.6
Linezolid - - 100 100
  1. *p = 0.02.